LY3981314

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3981314, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3981314 in Healthy Participants [Phase 1]